Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1750 of 3173 entries
View as:

A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00783484 Org: User:
Start: 10/31/08 End: 05/31/09 Due: 05/31/10

Latin American Real-world Study in Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05166135 Org: User:
Start: 12/10/21 End: 11/15/22 Due: 11/15/23

A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT06182124 Org: User:
Start: 12/20/23 End: 08/13/25 Due: 08/13/26

A STUDY TO LEARN HOW THE STUDY MEDICINE CALLED PF-07293893 AFFECTS MUSCLE BIOMARKERS OF HEALTHY ADULTS

Phase: N/A Priority: Normal
NCT ID: NCT06413693 Org: User:
Start: 05/23/24 End: 08/05/24 Due: 08/05/25

A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05654623 Org: User:
Start: 03/03/23 End: 05/15/28 Due: 05/15/29

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Phase: N/A Priority: Normal
NCT ID: NCT06531109 Org: User:
Start: 08/07/24 End: 12/31/27 Due: 12/31/28

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03387423 Org: User:
Start: 11/02/17 End: 07/17/23 Due: 07/17/24

Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00346268 Org: User:
Start: 12/31/06 End: 09/30/10 Due: 09/30/11

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants

Phase: N/A Priority: Normal
NCT ID: NCT04530838 Org: User:
Start: 09/16/20 End: 04/02/22 Due: 04/02/23

Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT02791230 Org: User:
Start: 06/13/16 End: 11/02/23 Due: 11/02/24

Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00793000 Org: User:
Start: 11/30/08 End: 12/31/09 Due: 12/31/10

A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05857644 Org: User:
Start: 06/07/23 End: 02/07/24 Due: 02/07/25

A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

Phase: N/A Priority: Normal
NCT ID: NCT04440176 Org: User:
Start: 06/17/20 End: 01/05/24 Due: 01/05/25

A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)

Phase: N/A Priority: Normal
NCT ID: NCT01989676 Org: User:
Start: 02/24/14 End: 06/27/20 Due: 06/27/21

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT01337765 Org: User:
Start: 07/08/11 End: 03/22/13 Due: 03/22/14

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT00039910 Org: User:
Start: 07/31/00 End: 03/31/03 Due: 03/31/04

Ngenla Subcutaneous Injection Special Investigation

Phase: N/A Priority: Normal
NCT ID: NCT05602766 Org: User:
Start: 02/06/23 End: 04/06/29 Due: 04/06/30

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00003293 Org: User:
Start: 02/28/98 End: 05/31/01 Due: 05/31/02

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02780167 Org: User:
Start: 04/30/16 End: 04/30/17 Due: 04/30/18

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Phase: N/A Priority: Normal
NCT ID: NCT02315066 Org: User:
Start: 04/23/15 End: 11/12/20 Due: 11/12/21

Safety and Efficacy Study in Adult Subjects With Acute Migraines

Phase: N/A Priority: Normal
NCT ID: NCT03235479 Org: User:
Start: 07/18/17 End: 01/26/18 Due: 01/26/19

A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.

Phase: N/A Priority: Normal
NCT ID: NCT01350596 Org: User:
Start: 05/31/11 End: 05/31/11 Due: 05/31/12

A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

Phase: N/A Priority: Normal
NCT ID: NCT01692886 Org: User:
Start: 08/31/12 End: 04/30/14 Due: 04/30/15

Descriptive Observational Study ALK-2016-CPHG

Phase: N/A Priority: Normal
NCT ID: NCT03718117 Org: User:
Start: 01/03/17 End: 07/01/20 Due: 07/01/21

A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.

Phase: N/A Priority: Normal
NCT ID: NCT06532357 Org: User:
Start: 06/09/24 End: 06/10/24 Due: 06/10/25